Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin
Zhiyuan Xu,1 Ronghua Ni,1 Yun Chen1,21School of Pharmacy, Nanjing Medical University, Nanjing 211166, People’s Republic of China; 2State Key Laboratory of Reproductive Medicine, Nanjing 210029, People’s Republic of ChinaCorrespondence: Yun ChenSchool of Pharmacy, Nanjing Medical...
Enregistré dans:
| Auteurs principaux: | Xu Z, Ni R, Chen Y |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/9b7e21103242479c8ff792d889d18abf |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
par: Do-Hun Kim, et autres
Publié: (2021) -
Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
par: Dou XQ, et autres
Publié: (2018) -
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
par: Yao F, et autres
Publié: (2020) -
Aptamer-Conjugated Quantum Dot Optical Biosensors: Strategies and Applications
par: Dongmin Kim, et autres
Publié: (2021) -
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
par: Javad Khanali, et autres
Publié: (2021)